We are live on ! Find out more
VRX

VALEANT PHARMACEUTICALS INTL
VRX

Delisted

VRX was delisted on the 27th of September, 2010.

Back to rankings

2 hedge funds and large institutions have $25K invested in VALEANT PHARMACEUTICALS INTL in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3 → 2 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

98% less capital invested

Capital invested by funds: $1.03M → $25K (-$1M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
AlphaMark Advisors
Kentucky
+$19K

Top Sellers

Rank Fund Capital Flow
1
CG
Colony Group
Massachusetts
-$945K
2
MMG
Monetary Management Group
Missouri
-$58K
3
SIM
Sonora Investment Management
Arizona
-$4.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
AlphaMark Advisors
Kentucky
$19K +$19K +186 New
SIM
2
Sonora Investment Management
Arizona
$6K -$4.6K -46 -43%
CG
3
Colony Group
Massachusetts
– -$945K -5,299 Closed
MMG
4
Monetary Management Group
Missouri
– -$58K -325 Closed

VRX Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q4 2015, worth a combined $25K — down 98% from $1.03M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VRX and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was AlphaMark Advisors, opening a new position worth an estimated $19K. The largest seller was Colony Group, exiting entirely with an estimated $945K sold.

  • 2 institutional investors held VALEANT PHARMACEUTICALS INTL (VRX) as of Q4 2015, down from 3 in Q3 2015.
  • Funds reported $25K of VALEANT PHARMACEUTICALS INTL stock for Q4 2015, down 98% quarter-over-quarter.
  • 1 fund opened new VALEANT PHARMACEUTICALS INTL positions in Q4 2015 and 2 closed out, a net change of -1 holder.
  • The largest VALEANT PHARMACEUTICALS INTL buyer in Q4 2015 was AlphaMark Advisors, an estimated $19K added.
  • The largest VALEANT PHARMACEUTICALS INTL seller in Q4 2015 was Colony Group, an estimated $945K sold.

Based on aggregated 13F filings for Q4 2015.